|1.||Fox, L K: 3 articles (02/2015 - 01/2002)|
|2.||Petersen, Bryan D: 3 articles (12/2008 - 03/2005)|
|3.||Sorenson, John R J: 3 articles (11/2004 - 01/2004)|
|4.||Dansky, Tanya: 2 articles (06/2014 - 01/2013)|
|5.||Bush, Ruth: 2 articles (06/2014 - 01/2013)|
|6.||Tompane, Trevor: 2 articles (06/2014 - 01/2013)|
|7.||Huang, Jeannie S: 2 articles (06/2014 - 01/2013)|
|8.||Schimek, Martina: 2 articles (11/2010 - 08/2009)|
|9.||Briegel, Wolfgang: 2 articles (11/2010 - 08/2009)|
|10.||Kamp-Becker, Inge: 2 articles (11/2010 - 08/2009)|
08/01/1998 - "Three postmilking teat dips were tested for efficacy against Staphylococcus aureus and Streptococcus agalactiae in two separate studies using experimental challenge procedures that were recommended by the National Mastitis Council. "
11/01/1997 - "The model for the experimental challenge in the trials that were designed to test the efficacy of the two postmilking teat dips was recommended by the National Mastitis Council. "
12/01/2000 - "We tested two postmilking teat dips for efficacy against Staphylococcus aureus and Streptococcus agalactiae using experimental challenge procedures recommended by the National Mastitis Council. "
10/01/1994 - "Two postmilking teat dips were tested for efficacy against Staphylococcus aureus and Streptococcus agalactiae using experimental challenge procedures recommended by the National Mastitis Council. "
01/01/2002 - "Application of the two new postmilking teat dips was effective in reducing new IMI from contagious mastitis pathogens. "
02/01/1975 - "Four teat dips were highly effective in reducing the incidence of udder infection. "
07/01/2006 - "Both dips were significantly effective in reducing new contagious intramammary infections. "
01/01/1998 - "Five Michigan dairy herds participated in a split-herd study to compare the efficacy of two postmilking teat dips in the prevention of new intramammary infections (IMI) in lactating cows. "
11/01/1980 - "The efficacy of teat dips of differing persistence on teat skin in preventing intramammary infection by Streptococcus uberis and Escherichia coli in dry cows."
01/01/2015 - "DIPs are not required for the initiation of persistent LGTV infection but may play a role in the maintenance of viral persistence. "
|3.||Asthma (Bronchial Asthma)
01/01/1997 - "We conclude that a subset of clinically stable asthma patients presents morning dips and nocturnal waking. "
04/01/1990 - "Four of these 14 patients were readmitted with acute severe asthma during the 8 weeks follow-up period; in contrast, none of the 16 patients without major dips required readmission. "
07/07/1984 - "Inhaled therapy for morning "dips" in asthma."
05/26/1984 - "Inhaled therapy reduces morning dips in asthma."
10/01/1981 - "Furthermore in patients with unstable bronchial asthma and in patients with morning dips in PEF the more stable plasma concentration may perhaps keep the patients in a more steady state."
01/01/1999 - "A decrease in NO synthesis in animal models of seizure and radiation injury may account for the anticonvulsant, radioprotectant, and radiorecovery activities of Mn(3)(3,5-DIPS)(6) and Cu(II)(2)(3,5-DIPS)(4)."
03/01/2002 - "It was pointed out that the Cu(2)(DIPS)(4)L(2) complexes (L=diethylether, N,N-dimethylformamide) exhibited no rotorod toxicity when examined for anticonvulsant activity using the seizure produced by maximal electroshock, following oral administration to rats."
11/01/2004 - "While the two ternary phenanthroline-containing complexes, 1 and 2, evidenced weak protection against maximal electroshock (MES)- and subcutaneous Metrazol (scMET) induced seizures, [Zn(II)(3,5-DIPS)(2)(DMSO)(2)], [Zn(II)(aspirinate)(2)(H(2)O)(2)], and bis(salicylato)-1,10-phenanthorlinezinc(II), [Zn(II)(salicylate)(2)(phen)], were found to be particularly useful in protecting against MES and scMET seizures and [Zn(II)(aspirinate)(2)(H(2)O)(2)] and [Zn(II)(salicylate)(2)(phen)] were found to have activity in protecting against Psychomotor seizures, without causing Rotorod toxicity. "
07/15/2000 - "Two binuclear copper(II) complexes of 3,5-diisopropylsalicylic acid were characterized by single crystal X-ray diffraction methods and examined for anti-inflammatory activity using activated polymorphonuclear leukocytes and for anticonvulsant activities using electroshock and metrazol models of seizures. "
01/01/1991 - "1. The effects of the octapeptide angiotensin II (AT II) on some types of behaviour [threshold of seizures induced by timed intravenous infusion of pentylenetetrazol (PTZ), exploratory behaviour: ambulation, rearing and head-dips on a hole-board, and passive avoidance performance--step-through paradigm] were studied following repeated systemic administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to mice (30 mg/kg, i.p., twice daily for 5 days). "
01/01/2007 - "An increase in apnea-hypopnea index (18.9 vs. 4.3; p = 0.007) and dips in the SaO(2) (> or =4%) per hour of sleep (22.6 vs. 6.4; p = 0.021) were also significantly greater in hemodialysis patients than controls. "
01/01/2007 - "The patients on hemodialysis showed poor sleep quality with a significant increase in the apnea-hypopnea index and in the number of dips in SaO(2). "
06/07/2010 - "In conclusion, V/Q mismatch causes a more immediate onset of desaturation during apnea, and therefore places preterm infants and adults with lung disease at risk of hypoxemic dips. "
04/01/2005 - "Sleep-disordered breathing was assessed by the apnea-hypopnea index, the SaO(2) nadir, and the desaturation index, including dips in saturation below 90% (DI(90)). "
07/01/2007 - "Breathing flow, pressure, CO2 air concentration, and SpO2 showed that the model mimicked OSA respiratory events (obstructive apneas, increased respiratory efforts, and oxygen saturation dips). "
|5.||Dimethyl Sulfoxide (DMSO)
|6.||Bronchodilator Agents (Bronchodilators)
|8.||diazenedicarboxylic acid bis(N'-methylpiperazide)
|9.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Renal Dialysis (Hemodialysis)
|4.||Intensive Care (Surgical Intensive Care)